Zhimin He Selected Research

Tongue Neoplasms (Tongue Neoplasm)

4/2022	TCRP1 activated by mutant p53 promotes NSCLC proliferation via inhibiting FOXO3a.
3/2017	TCRP1 expression is associated with platinum sensitivity in human lung and ovarian cancer cells.
1/2017	Epigenetic silencing of miR-493 increases the resistance to cisplatin in lung cancer by targeting tongue cancer resistance-related protein 1(TCRP1).
1/2017	TCRP1 transcriptionally regulated by c-Myc confers cancer chemoresistance in tongue and lung cancer.
10/2016	MYCN-mediated miR-21 overexpression enhances chemo-resistance via targeting CADM1 in tongue cancer.
8/2015	The 14-3-3σ/GSK3β/β-catenin/ZEB1 regulatory loop modulates chemo-sensitivity in human tongue cancer.
4/2015	ZEB1 transcriptionally regulated carbonic anhydrase 9 mediates the chemoresistance of tongue cancer via maintaining intracellular pH.
3/2015	The miR-491-3p/mTORC2/FOXO1 regulatory loop modulates chemo-sensitivity in human tongue cancer.
1/2015	TCRP1 contributes to cisplatin resistance by preventing Pol β degradation in lung cancer cells.
4/2012	Purification and biochemical characterization of a novel protein-tongue cancer chemotherapy resistance-associated protein1 (TCRP1).

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhimin He Research Topics

Disease

44	Neoplasms (Cancer) 04/2022 - 09/2007
29	Breast Neoplasms (Breast Cancer) 11/2021 - 09/2007
13	Tongue Neoplasms (Tongue Neoplasm) 04/2022 - 11/2010
7	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2012
6	Lung Neoplasms (Lung Cancer) 01/2017 - 09/2014
4	Triple Negative Breast Neoplasms 01/2022 - 11/2018
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2021 - 06/2015
3	Adenocarcinoma 07/2022 - 06/2007
3	Amyloidosis 05/2020 - 01/2019
3	Leukemia 01/2018 - 06/2015
3	Hepatocellular Carcinoma (Hepatoma) 01/2016 - 10/2012
3	Squamous Cell Carcinoma of Head and Neck 01/2015 - 03/2011
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2022 - 11/2010
2	Alzheimer Disease (Alzheimer's Disease) 05/2021 - 05/2020
2	Infections 01/2021 - 02/2017
2	Proteostasis Deficiencies 01/2021 - 01/2020
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 10/2005
2	Multiple Myeloma 01/2020 - 01/2018
2	Carcinogenesis 11/2017 - 01/2017
2	Hypoxia (Hypoxemia) 01/2016 - 04/2012
2	Wounds and Injuries (Trauma) 09/2013 - 03/2013
2	Carcinoma (Carcinomatosis) 04/2013 - 04/2012
1	Cryptococcosis 07/2022
1	Disease Progression 01/2021
1	HIV Infections (HIV Infection) 05/2020
1	Amyloid Plaque 01/2020
1	Bites and Stings (Sting) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020
1	Chronic Hepatitis C 01/2020

Drug/Important Bio-Agent (IBA)

26	Proteins (Proteins, Gene)FDA Link 04/2022 - 09/2007
17	Pharmaceutical PreparationsIBA 01/2021 - 05/2009
13	Cisplatin (Platino)FDA LinkGeneric 03/2017 - 11/2010
9	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 05/2009
7	Biomarkers (Surrogate Marker)IBA 07/2022 - 05/2009
7	Long Noncoding RNAIBA 10/2021 - 01/2018
7	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2014
5	Metformin (Glucophage)FDA LinkGeneric 06/2021 - 10/2012
5	DNA (Deoxyribonucleic Acid)IBA 05/2020 - 04/2012
4	Trastuzumab (Herceptin)FDA Link 11/2021 - 01/2015
4	Amyloid (Amyloid Fibrils)IBA 05/2021 - 01/2019
4	Peptides (Polypeptides)IBA 05/2020 - 10/2015
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 11/2010
3	CateninsIBA 01/2022 - 03/2015
3	Tamoxifen FDA LinkGeneric 10/2021 - 12/2017
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 11/2010
3	Messenger RNA (mRNA)IBA 01/2018 - 01/2015
3	CaspasesIBA 01/2018 - 10/2010
2	Insulin (Novolin)FDA Link 05/2021 - 05/2020
2	CollagenIBA 01/2021 - 02/2013
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 03/2015
2	CurcuminIBA 01/2021 - 01/2020
2	Cystine (L-Cystine)IBA 01/2020 - 01/2020
2	DisulfidesIBA 01/2020 - 05/2018
2	RNA (Ribonucleic Acid)IBA 06/2019 - 12/2017
2	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2019 - 06/2015
2	SurvivinIBA 01/2018 - 01/2018
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2018 - 09/2016
2	Deubiquitinating EnzymesIBA 01/2018 - 09/2016
2	Small Interfering RNA (siRNA)IBA 12/2017 - 01/2017
2	PlatinumIBA 03/2017 - 09/2016
2	Lapatinib (GW572016)FDA Link 01/2016 - 01/2015
2	AMP-Activated Protein KinasesIBA 01/2016 - 01/2014
2	Fingolimod Hydrochloride (FTY720)FDA Link 06/2015 - 12/2014
2	Carbonic Anhydrase IXIBA 04/2015 - 11/2010
2	Indicators and Reagents (Reagents)IBA 04/2015 - 01/2013
2	Adenosine Triphosphate (ATP)IBA 10/2012 - 09/2007
2	human ERBB2 proteinIBA 08/2011 - 06/2007
2	NF-kappa B (NF-kB)IBA 08/2011 - 08/2010
1	antigen CYFRA21.1IBA 07/2022
1	glucuronoxylomannanIBA 07/2022
1	Polysaccharides (Glycans)IBA 07/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Vancomycin FDA LinkGeneric 01/2021
1	Docetaxel (Taxotere)FDA Link 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	AnthraquinonesIBA 01/2021
1	poly(lactide) (polylactic acid)IBA 01/2021
1	Betaine (C.B.B.)FDA Link 07/2020
1	EnzymesIBA 05/2020
1	Nucleic AcidsIBA 05/2020
1	Green Fluorescent ProteinsIBA 01/2020
1	LigandsIBA 01/2020
1	MicellesIBA 01/2020
1	MetalsIBA 01/2020
1	Biological ProductsIBA 01/2020
1	velpatasvirIBA 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2020
1	trifluridine tipiracil drug combinationIBA 01/2020
1	Ribavirin (Virazole)FDA LinkGeneric 01/2020
1	Metal-Organic FrameworksIBA 01/2020
1	SofosbuvirIBA 01/2020
1	asunaprevirIBA 01/2020
1	InterferonsIBA 01/2020
1	IonsIBA 01/2020
1	daclatasvirIBA 01/2020

Therapy/Procedure

22	Drug Therapy (Chemotherapy) 01/2020 - 09/2007
15	Therapeutics 01/2020 - 05/2009
2	Length of Stay 01/2018 - 01/2018
2	Radiotherapy 10/2012 - 07/2011